Healthcare & Biotech
Pro Medicus Share Price Falls 5% as Healthcare’s Rally Runs Out of Road
Same sell-off, different stories. Pro Medicus has a real question. ResMed has less new news.
The Investor Standard – Your Investing Edge
Receive curated weekly stock picks, top-performing equities, and actionable investment ideas to maximise your portfolio potential.
Investor Insights, Delivered
Unlock expert insights, stock recommendations, and market analysis – all in one place. Get the latest market news and stock picks instantly.
Further Analysis & Commentary
Flok Health: The AI Clinician That Just Redefined Healthcare
A Turning Point in European Medicine Cambridge-based Flok Health has reached a major milestone, securing an oversubscribed $12.5 million Series…
CSL Limited (ASX: CSL): Equity Analysis
Rating ACCUMULATE Price (8 Jun 2026) A$97.91 Consensus target A$141.45 Implied upside ~44% Consensus (16 analysts) 7 Buy / 9…
ŌURA’s IPO Signals the Dawn of the Health‑Intelligence Era
A Different Kind of Wearable Goes Public ŌURA’s decision to pursue an IPO at an $11 billion valuation represents a…
Executive Interview: Sarah Horton of Elme Health on Preventive Healthcare and the Future of Healthcare
In the latest instalment of The Investor Standard’s CEO & Executive Interviews series, our analyst Peter Boyd sat down with…
Socials
Monthly Investor Memo
Delivered Monthly - 2026